Breaking News
November 19, 2018 - Biologists uncover novel genetic control of lipid maintenance and its potential connection to lifespan
November 19, 2018 - Warmer winters may set scene for higher rates of violent crimes
November 19, 2018 - Acacia Pharma Resubmits Barhemsys New Drug Application
November 19, 2018 - PDL1 (Immunotherapy) Tests: MedlinePlus Lab Test Information
November 19, 2018 - Transforming pregnancy research with a smartphone app
November 19, 2018 - Stanford Medicine magazine explores how digital technology is changing health care
November 19, 2018 - New report calls for greater awareness and emphasis on scale and impact of atrial fibrillation
November 19, 2018 - In throes of turkey salmonella outbreak, don’t invite illness to your table
November 19, 2018 - UK health policies should be redesigned to become more accessible for men
November 19, 2018 - Short Interpregnancy Intervals Tied to Adverse Outcome Risk
November 19, 2018 - New mothers’ breastfeeding pain can affect infant health
November 19, 2018 - Stanford Medicine magazine reports on ways digital technology is transforming health care | News Center
November 19, 2018 - Human drugs alter cricket personality
November 19, 2018 - Insilico Medicine to introduce ‘Cure a disease in a year’ program at Biodata World Congress 2018
November 19, 2018 - Experts debate over whether gut or brain is more important in regulating appetite
November 19, 2018 - Playing on fear and fun, hospitals follow pharma in direct-to-consumer advertising
November 19, 2018 - 2PG Company receives grant to develop sensitive, low-cost molecular diagnostic tests for tuberculosis
November 19, 2018 - Low-Carb Diets May Work By Boosting Calorie Burn
November 19, 2018 - Key molecule responsible for learning and memory discovered
November 19, 2018 - New blood test developed for early diagnosis of ovarian cancer
November 19, 2018 - Researchers identify molecule to fight myotubular myopathy
November 19, 2018 - New solution to stop spread of brain cancer
November 19, 2018 - Immune cells trigger OCD-like behaviour in multiple sclerosis, study finds
November 19, 2018 - Scientists equip new virus that kills carcinoma cells with protein
November 19, 2018 - Novel approach could provide painless, efficient alternative for treating eye diseases
November 19, 2018 - Protein in cell membranes of sperm plays key role in finding their way to eggs
November 19, 2018 - Parents who decline flu vaccination for their child may be exposed to limited information
November 19, 2018 - Mirati Presents Data From Ongoing Phase 2 Clinical Trial Of Mocetinostat In Combination With Durvalumab At The SITC 33rd Annual Meeting
November 19, 2018 - FDA warns of common diabetes meds’ link to dangerous genital infection
November 19, 2018 - New methods for preserving shoulder function, quality of life in breast cancer patients
November 19, 2018 - Surprising discovery about BH4 may rekindle interest in once-promising pathway
November 19, 2018 - Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections
November 19, 2018 - Beating breast cancer only to die of opioid use – a sad Appalachian story
November 19, 2018 - Workplace bullying or violence linked to higher risk of cardiovascular problems
November 19, 2018 - Changes in Risk Indicators of MetS Severity Tied to T2DM Risk
November 19, 2018 - ‘Game-changing’ skin sensor could improve life for a million hydrocephalus patients
November 19, 2018 - Alcohol ads on social media sites with pro-drinking comments increase desire to drink
November 19, 2018 - Neural networks could replace marker genes in RNA sequencing
November 19, 2018 - Obese adolescents feel less food enjoyment than those with normal weight, study reveals
November 18, 2018 - Goodbye ‘Gluten-Free’? Celiac Disease Vaccine May Make It Possible
November 18, 2018 - Skin ages when the main cells in the dermis lose their identity and function
November 18, 2018 - Rainforest vine compound makes pancreatic cancer cells susceptible to nutrient starvation
November 18, 2018 - A new mechanism in the control of inflammation
November 18, 2018 - Age-related decline in abstract reasoning ability predicts depressive symptoms over time
November 18, 2018 - Scientists succeed in increasing stability, biocompatibility of light-transducing nanoparticles
November 18, 2018 - Sugar, a ‘sweet’ tool to understand brain injuries
November 18, 2018 - Pharmacist-Led Effort Cuts Inappropriate Rx in Older Adults
November 18, 2018 - Novel discovery could lead to new cancer, autoimmune disease therapy
November 18, 2018 - AHA and ADA launch new initiative to help people with type 2 diabetes reduce heart disease risk
November 18, 2018 - Balanced production of pro and anti-inflammatory cytokines at two years of age protects against malaria
November 18, 2018 - New pharmacological agent shows promise for prevention of heart rhythm disorders
November 18, 2018 - All That Social Media May Boost Loneliness, Not Banish It
November 18, 2018 - Scientists shine new light on link between obesity and cancer
November 18, 2018 - Risk factors for cardiovascular disease closely track with changes in diet patterns
November 18, 2018 - Biogen Scoops Sixth Prix Galien Award with UK Win for Life-Changing Rare Disease Medicine
November 18, 2018 - Detectable HIV-1 in treated human liver cells found to be inert
November 18, 2018 - Using light to control crucial step in embryonic development
November 18, 2018 - Unusual case of father-to-son HIV transmission reported
November 18, 2018 - FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea
November 18, 2018 - Poverty blamed on widening north-south gap in young adult deaths in England
November 18, 2018 - Progress in meningitis lags far behind other vaccine-preventable diseases, analysis shows
November 18, 2018 - Consensus Statement Issued on Management of Foot, Ankle Gout
November 18, 2018 - Fine particle air pollution is a public health emergency hiding in plain sight
November 18, 2018 - In-hospital mortality higher among patients with drug-resistant infections
November 17, 2018 - Research shines new, explanatory light on link between obesity and cancer
November 17, 2018 - FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings
November 17, 2018 - Tracking Preemies’ Head Size May Yield IQ Clues
November 17, 2018 - Scientists call for unified standards in 3-D genome and epigenetic data
November 17, 2018 - Lab Innovations 2018 has beaten all records by attracting 3,113 attendees
November 17, 2018 - New strategy to hinder emergence of antimicrobial-resistant pathogens
November 17, 2018 - Sexuality education before age 18 may reduce risk of sexual assault in college
November 17, 2018 - Reducing cellular proliferation could help deplete HIV reservoir and lead to a functional cure
November 17, 2018 - New model of FSHD could be useful to study effectiveness of experimental therapeutics
November 17, 2018 - FDA approves antibacterial drug to treat travelers’ diarrhea
November 17, 2018 - Lab Innovations 2018 confirmed as a major hit with visitors, exhibitors and speakers
November 17, 2018 - Largest parasitic worm genetic study hatches novel treatment possibilities
November 17, 2018 - UCLA biologists uncover how head injuries can lead to serious brain disorders
November 17, 2018 - Static and dynamic physical activities offer varying protection against heart disease
November 17, 2018 - Obesity significantly increases risk of Type 2 diabetes and coronary artery disease
November 17, 2018 - New method to analyze cell membrane complexes could revolutionize the way we study diseases
Stanford researchers find that small molecule may help treat enzyme deficiency

Stanford researchers find that small molecule may help treat enzyme deficiency

image_pdfDownload PDFimage_print

Scientists are one step closer to developing a treatment for a genetic enzyme deficiency that can cause red blood cells to break down in response to infections or certain drugs or foods, like fava beans. In extreme cases, reactions can be fatal.

The research, led by Stanford’s Daria Mochly-Rosen, PhD, and Sunhee Hwang, PhD, identified a small molecule that can patch up the defective enzyme. The goal is to convert this molecule into a safe daily treatment for people with the enzyme deficiency.

The research appears in Nature Communications.

When it functions properly, the enzyme, called glucose-6-phosphate dehydrogenase or G6PD, protects red blood cells from oxidative stress, which occurs when unstable atoms called free radicals steal electrons from red blood cells’ protective membrane, causing them to break down.

However more than 400 million individuals worldwide are born with mutated G6PDs, leaving their cells more susceptible to oxidative stress and deterioration. When exposed to specific foods, medications, infections or environmental factors, patients can experience hemolytic anemia, where their red blood cells are destroyed faster than the body can produce them. This results in symptoms such as abdominal pain, increased heart rate, shortness of breath, fever, jaundice and brain damage in severe cases or if left untreated.

Many of the people with the G6PD mutation live where malaria is common. Unfortunately, chloroquine, a commonly used antimalarial drug in low and middle income countries, is known to trigger hemolytic anemia in G6PD-deficient patients. Due to limited resources, malaria patients in these regions are rarely tested for G6PD deficiency before taking chloroquine. This puts individuals with the disorder in a dangerous predicament.

Mochly-Rosen and Hwang don’t believe that patients should have to choose between malaria or a hemolytic episode.

They thought the molecule they had found, known as activator of G6PD-1 (abbreviated as AG1), might provide some protection from the condition. To see, the researchers and collaborator Karen Mruk, PhD, exposed zebrafish embryos to chloroquine, causing blood to pool in the veins and physical changes in the embryo’s structure. Incredibly, when they treated the embryos with AG1, they noticed a decrease in both oxidative stress and the physical defects. Long term, the goal is to give a drug similar to AG1 together with chloroquine for people with G6PD deficiency who are exposed to malaria.

However, moving from fish to humans is a tricky business.

Along with correcting G6PD-deficiency, AG1 has an additional purpose. By testing AG1 on human blood samples, the team found that the molecule helps prolong red blood cells’ 42-day shelf-life by reducing the rate of hemolysis. This could be a huge help in lengthening the amount of available time between blood donation and transfusion.

But, “even though we have some promising data, this molecule is quite a mild activator,” Hwang said. “We want to increase the mutant G6PD enzyme activity to 60 percent of the normal enzyme, which is known to be sufficient in humans. As of now, we have only activated it by 20 or 30 percent.”

Currently, Andrew Raub, a graduate student who is working in the Mochly-Rosen lab, is trying to make a new form of AG1 that can be used in human trials. By examining the crystal structure of AG1, the team can understand where the molecule binds and create a more stable and effective drug.

And the new molecule could help with more than just red blood cells, Mochly-Rosen believes.

“It is assumed that the deficiency in this enzyme is only important for maintaining the integrity of red blood cells,” Mochly-Rosen said. “But I’m quite confident that this is really an underestimation of the contribution of this mutation to human health.”

For Mochly-Rosen, this study also holds personal significance. In addition to activator of G6PD, the acronym AG stands for the initials of the University of California, San Francisco professor and neuroscientist Adrienne Gordon, a close friend and mentor of Mochly-Rosen who died in 2015. “She was my mentor since graduate school, I was always bouncing ideas against her, and she love this G6PD project. And so, we named the molecule AG for her as well.”

Photo of Sunhee Hwang, at left, and Daria Mochly-Rosen by Helen Santoro

Tagged with:

About author

Related Articles